The Food and Drug Administration (FDA) is pleased to announce this joint conference with the University of Rhode Island (URI) College of Pharmacy. This 2-day conference is co-sponsored by FDA, the URI College of Pharmacy, and Pharma Conference Inc. The conference is intended to disseminate current and accurate information on Process Analytical Technology (PAT) to the pharmaceutical industry and create a venue for dialogue between the PAT users and FDA. The conference will feature FDA’s perspective on where PAT will be applicable in the manufacturing process and FDA’s current thinking on how PAT will be reviewed in new and abbreviated new drug applications, amendments, or supplements to an application.